Community/Retail

Dapagliflozin is the first SGLT2 inhibitor approved by the FDA for treatment of patients with heart failure (NYHA class II-IV) with reduced ejection fraction.

Patients administered 75 mg or higher of olpasiran every 12 weeks had a 95% or greater reduction in Lp(a) compared to placebo at week 36.

Five hours or less hours of sleep per night at 50 years of age was associated with a 25% higher risk of mortality over 25 years of follow-up.

Patients with Alzheimer disease administered gantenerumab did experience slower clinical decline, however, it was not deemed statistically significant.

There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.

Patients with this skin condition must make an ongoing commitment to their therapy regimen for best results.

Guselkumab (Tremfya) is a fully human selective IL-23 inhibitor therapy FDA-approved for the treatment of adults with active psoriatic arthritis and with moderate to severe plaque psoriasis.

Investigational migraine drug produces significant effects on both freedom-from-pain and MBS-free endpoints at 3 hours post administration and at additional efficacy measurement timepoints of 4, 6, 12, 24 and 48 hours.

Analysis of central Missouri discovers differences in co-infection occurrence between Delta and Omicron variants.

Collaboration can manifest as referrals, joint community outreach, and networking.

cobas MPXV targets 2 different regions of the monkeypox virus genome that are less prone to mutations than other parts of the genome.

Pharmacy school is about more than academics—it's also a time to build relationships and explore opportunities.

In a 2019 survey, middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups, which was not the case in the 2022 survey.

A plethora of products complicates self-care, but pharmacists can provide guidance on nonprescription options.

Currently, no national pharmacy organization has defined wellness in the pharmacy profession, which is needed so that others have a sense of guidance around wellness within the profession.

In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.

Anxiety disorders include generalized anxiety, social anxiety, panic disorder, and fear of certain places or situations, including crowds and public transportation.

Approximately 80% of all HIV infections among teens are from the gay and bisexual population.

Most pharmacists and technicians are unaware of resources that aid in communication.

NVX-CoV2373 is a protein-based vaccine developed from the genetic sequence of the first strain of SARS-CoV-2.

Dapagliflozin and standard of care found to slow the decline in kidney function and lower the incidence of kidney failure.

New COVID-19 variants are always cause for concern but are not a cause for panic.

PrEP reduces the risk of getting HIV from sex by about 99% for certain patient population with consistent adherence.

Zilucoplan is a subcutaneous, self-administered peptide inhibitor of complement component 5.

Pharmacists can provide their knowledge to female patients but also ensure women are adequately represented in research.

Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.

Pharmacists can offer advice on nonpharmacologic and pharmacologic prevention and treatment strategies.

New continuous glucose monitor systems provide additional support and quality of life improvements for patients with diabetes.

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

States with a higher prevalence of Medicaid patients with type 2 diabetes were found to have lower use ratio of glucose-lowering agents with known cardiovascular benefits.